Integrated proteomic and phosphoproteomic data-independent acquisition data evaluate the personalized drug responses of primary and metastatic tumors in colorectal cancer

导出学术成果认领

作者 Xumiao Li ^[1] Yiming Huang ^[2] Kuo Zheng ^[3] Guanyu Yu ^[3] Qinqin Wang ^[1] Lei Gu ^[1] Jingquan Li ^[1] Hui Wang ^[1] Wei Zhang ^[3] Yidi Sun ^[2] Chen Li ^[1] 学术成果认领

作者单位 Center for Single-Cell Omics,School of Public Health,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China ^[1] Institute of Neuroscience,CAS Center for Excellence in Brain Science and Intelligence Technology,Chinese Academy of Sciences,Shanghai 200031,China ^[2] Colorectal Surgery Department,Changhai Hospital,Naval Medical University,Shanghai 200433,China ^[3]

关键词 Proteomics Phosphoproteomics Data-independent acquisition(DIA)Mini patient derived xenograft(MiniPDX)Kinase-substrate network Personalized drug responses

栏目名称

PROTOCOL

DOI 10.52601/bpr.2022.210048

发布时间 2023-10-19

浏览1
被引0
下载0

生物物理学报(英文)

2023年9卷2期

67-81页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Integrated proteomic and phosphoproteomic data-independent acquisition data evaluate the personalized drug responses of primary and metastatic tumors in colorectal cancer

生物物理学报(英文)

相似文献

生物物理学报(英文)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Integrated proteomic and phosphoproteomic data-independent acquisition data evaluate the personalized drug responses of primary and metastatic tumors in colorectal cancer

生物物理学报(英文)

相似文献

生物物理学报(英文)

相关期刊

检索历史清除